Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | TNKS2 | Q9H2K2 | 3/20 | 0.37 |
| ▸ | TNKS | O95271 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MAP3K9 | P80192 | 3/20 | 0.35 |
| ▸ | MAP3K11 | Q16584 | 3/20 | 0.35 |
| ▸ | CDK4 | P11802 | 2/20 | 0.35 |
| ▸ | CCND1 | P24385 | 2/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.32 |
| ▸ | MAP3K10 | Q02779 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19546422 | 0.93 | MAP3K9 (0.40) | MEN1KMT2AKDM4EHCRTR1ALDH1A1 | |
| SCHEMBL19890942 | 0.92 | KDM4E (0.37) | MEN1KMT2AKDM4EHCRTR1ALDH1A1 | |
| SCHEMBL18132849 | 0.85 | MEN1 (0.41) | MEN1KMT2AKDM4EHCRTR1ALDH1A1 | |
| SCHEMBL14951206 | 0.84 | MEN1 (0.48) | MEN1KMT2AKDM4EHCRTR1ALDH1A1 | |
| SCHEMBL15796887 | 0.84 | MEN1 (0.37) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL15337951 | 0.83 | KDM4E (0.38) | MEN1KMT2AKDM4EHCRTR1ALDH1A1 | |
| SCHEMBL16482699 | 0.83 | KDM4E (0.40) | MEN1KMT2AKDM4EMAPTRAB9A | |
| SCHEMBL20390242 | 0.82 | ATM (0.41) | MEN1KMT2AKDM4EALDH1A1TNKS2 | |
| SCHEMBL18688072 | 0.82 | KDM4E (0.37) | MEN1KMT2AKDM4EHCRTR1ALDH1A1 | |
| SCHEMBL21709326 | 0.82 | MEN1 (0.40) | MEN1KMT2AKDM4EHPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240141-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-27 | — | — | US | disclosed |
| WO-2021230650-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2021-11-18 | — | — | WO | disclosed |
| US-20190229271-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT | DUK SAN NEOLUX CO., LTD. (KR) | 2019-07-25 | — | — | US | disclosed |
| WO-2018012780-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT | 덕산네오룩스 주식회사 | 2018-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240141-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | ESR1, GPX1, LEF1 | MEN1 652/4885KMT2A 1921/4885KDM4E 1003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.